Design and Synthesis of New Modified Flexible Purine Bases as Potential Inhibitors of Human PNP
Molecules · 2023
DOI: 10.3390/molecules28030928 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Anastasia Khandazhinskaya und 7 weiteren Autor:innen. Beteiligte Einrichtung: Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia. Hauptthemen laut MEDLINE: Purine-Nucleoside Phosphorylase, Escherichia coli. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.
Abstract (Originalsprache)
The great interest in studying the structure of human purine nucleoside phosphorylase (hPNP) and the continued search for effective inhibitors is due to the importance of the enzyme as a target in the therapy of T-cell proliferative diseases. In addition, hPNP inhibitors are used in organ transplant surgeries to provide immunodeficiency during and after the procedure. Previously, we showed that members of the well-known fleximer class of nucleosides are substrates of E. coli PNP. Fleximers have great promise as they have exhibited significant biological activity against a number of viruses of pandemic concern. Herein, we describe the synthesis and inhibition studies of a series of new fleximer compounds against hPNP and discuss their possible binding mode with the enzyme. At a concentration of 2 mM for the flex-7-deazapurines 1–4, a decrease in enzymatic activity by more than 50% was observed. 4-Amino-5-(1H-pyrrol-3-yl)pyridine 2 was the best inhibitor, with a Ki = 0.70 mM. Docking experiments have shown that ligand 2 is localized in the selected binding pocket Glu201, Asn243 and Phe200. The ability of the pyridine and pyrrole fragments to undergo rotation around the C–C bond allows for multiple binding modes in the active site of hPNP, which could provide several plausible bioactive conformations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia.
- Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.
- Department of Chemistry & Biochemistry, University of Maryland, Baltimore County, Baltimore, MD 21250, USA.
ORCID-Profile: Anastasia Khandazhinskaya, Ilja Fateev, Barbara Eletskaya, Katherine Seley-Radtke, Sergey Kochetkov, Elena Matyugina
Förderung
- Russian Science Foundation
Zitieren
APA
Khandazhinskaya, A., Fateev, I., Eletskaya, B., Maslova, A., Konstantinova, I., Seley-Radtke, K., Kochetkov, S., & Matyugina, E. (2023). Design and Synthesis of New Modified Flexible Purine Bases as Potential Inhibitors of Human PNP. Molecules. https://doi.org/10.3390/molecules28030928
Vancouver
Khandazhinskaya A, Fateev I, Eletskaya B, Maslova A, Konstantinova I, Seley-Radtke K, et al. Design and Synthesis of New Modified Flexible Purine Bases as Potential Inhibitors of Human PNP. Molecules. 2023. doi:10.3390/molecules28030928
BibTeX
@article{Khandazhinskaya2023,
author = {Khandazhinskaya, Anastasia and Fateev, Ilja and Eletskaya, Barbara and Maslova, Anna and Konstantinova, Irina and Seley-Radtke, Katherine and Kochetkov, Sergey and Matyugina, Elena},
title = {Design and Synthesis of New Modified Flexible Purine Bases as Potential Inhibitors of Human PNP},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28030928}
}
EUVIMED